Here, we describe a patient with bilateral multifocal lung adenocarcinoma harboring a very rare <i>EGFR</i> exon 20 insertion (c.2317_2319dup3; p.H773dup), who has been receiving treatment with afatinib for 4.5 years. This evidence concerns the gene EGFR and lung adenocarcinoma.